Written by Klarity Editorial Team
Published: May 15, 2026

If you’re a psychiatrist or PMHNP exploring telehealth opportunities for treating anxiety disorders, you’re probably wondering: Can I legally prescribe anti-anxiety medications remotely? What about controlled substances like benzodiazepines? And how does my state’s scope of practice affect what I can do?
The short answer: Yes, psychiatrists can prescribe anxiety medications via telehealth in all 50 states — including controlled substances — thanks to extended federal flexibilities running through December 2026. But the details matter, especially if you’re an NP navigating varying state laws or trying to understand reimbursement.
Here’s what you actually need to know to practice anxiety medication management via telehealth in 2026 — without the regulatory confusion.
Before COVID-19, the Ryan Haight Act required at least one in-person visit before prescribing any controlled substance. That meant if a patient needed a benzodiazepine for panic disorder, you couldn’t initiate it via telehealth alone.
That changed in March 2020. The DEA suspended the in-person requirement, allowing providers to prescribe Schedule II–V controlled substances (including anxiety medications like alprazolam, clonazepam, and even stimulants for comorbid ADHD) entirely through virtual visits.
Here’s the critical update for 2026: The DEA and HHS have extended these telehealth flexibilities through December 31, 2026. This means psychiatrists can continue prescribing benzodiazepines, SSRIs, SNRIs, and other anxiety medications via telehealth without requiring an initial in-person exam.
Why the extension? Data shows over 7 million controlled substance prescriptions were written via telemedicine in 2024 alone. Ending the flexibility abruptly would have created a ‘telemedicine cliff,’ cutting off access for millions of patients managing anxiety and other mental health conditions.
What happens after 2026? The DEA is crafting permanent telemedicine prescribing regulations — likely requiring some form of special registration or patient verification — but the details aren’t finalized. For now, you’re clear to practice telehealth anxiety care with your full prescriptive authority through the end of 2026.
While federal law sets the baseline, state regulations determine who can prescribe what, and under what conditions. This is especially important for PMHNPs, whose authority varies dramatically by state.
If you’re a licensed psychiatrist, you can prescribe any anxiety medication — SSRIs, SNRIs, benzodiazepines, beta-blockers, buspirone, even off-label options — in all 50 states via telehealth, as long as you’re licensed in the state where the patient is located.
No supervision required. No collaborative agreements. No quantity limits.
The only requirements:
For psychiatric nurse practitioners, prescribing authority for anxiety medications — especially controlled substances — varies by state practice laws.
Full Practice Authority States (NPs Can Prescribe Independently):
In about half of U.S. states, PMHNPs can evaluate, diagnose, and prescribe anxiety medications (including benzodiazepines) without any physician oversight. Their authority is essentially equivalent to a psychiatrist’s.
Examples:
Reduced/Restricted Practice States (NPs Need Physician Collaboration):
In other states, PMHNPs must maintain a formal relationship with a physician to prescribe medications.
Texas:
Florida:
Pennsylvania:
Illinois:
Bottom line: If you’re a PMHNP, your ability to prescribe anxiety medications independently depends entirely on where you’re licensed. In restrictive states, you’ll need a psychiatrist or physician willing to collaborate — which can be a barrier, especially in rural areas or for pure-telehealth practices.
Most states align with federal telehealth prescribing rules, but a few impose additional requirements:
Florida generally prohibits teleprescribing of Schedule II controlled substances (stimulants, some opioids) — with a critical exception: psychiatric treatment.
If you’re treating a mental health condition (anxiety, ADHD, treatment-resistant depression), you can prescribe Schedule II medications via telehealth in Florida. This matters if you’re managing a patient with severe anxiety and comorbid ADHD who needs both an SSRI and a stimulant.
Benzodiazepines (Schedule IV) have no telehealth restriction in Florida.
Important: Florida’s Out-of-State Telehealth Provider Registration allows providers licensed elsewhere to treat Florida patients remotely — but those with only the telehealth registration cannot prescribe controlled substances. You need a full Florida medical license for that.
Texas law prohibits using telemedicine to treat chronic pain with controlled substances. This is aimed at opioid prescribing, not psychiatric care.
For anxiety treatment: You’re clear to prescribe benzodiazepines or other anxiolytics via telehealth in Texas, as long as you’ve established a valid patient relationship through live audio-visual exam.
These states follow federal telehealth rules without additional state-level barriers to prescribing anxiety medications remotely.
All require PDMP checks before prescribing controlled substances:
Short answer: Yes, for mental health services.
Thanks to temporary COVID-era policies (extended through at least 2025–2026) and permanent state parity laws, Medicare and most private insurers pay for telehealth psychiatric visits at the same rate as in-person visits.
These are national averages; rates vary slightly by geographic locality.
One Medicare caveat: There was a proposed requirement that patients have an in-person visit within 6 months of starting tele-mental health services (and annually thereafter). However, enforcement of this rule has been postponed through at least late 2025, and many expect it will be delayed further or dropped entirely given telehealth’s proven effectiveness.
Significantly lower than Medicare — often 50–60% of Medicare rates. For example:
However, Medicaid volumes can be high, and many states have permanently expanded telehealth coverage for mental health with equal reimbursement to in-person.
Most commercial plans pay 100–150% of Medicare rates. Expect $100–$120 for a standard 15-minute med check, $150–$250 for initial evaluations.
Telehealth parity laws in California, Illinois, New York, and many other states prohibit insurers from paying lower rates simply because the service was delivered via telehealth.
Here’s the catch for nurse practitioners: Medicare reimburses NP services at 85% of the physician fee schedule when billing under the NP’s own NPI.
So if a psychiatrist gets $100 for a visit, an NP gets $85 for the same service.
Most private insurers follow a similar discount, though some Medicaid programs pay NPs at the same rate as MDs. This is why some practices have NPs bill ‘incident to’ a supervising physician (to get the full 100% rate) — but this generally doesn’t work in telehealth or psychiatric practice due to supervision requirements.
For platforms like Klarity: This reimbursement difference is typically baked into provider compensation models, but it’s worth understanding if you’re comparing offers.
Let’s talk about patient acquisition — because this is where DIY marketing vs. telehealth platforms diverges sharply.
If you’re building your own practice (virtual or in-person), acquiring qualified psychiatric patients is expensive and time-consuming:
SEO (Search Engine Optimization):
Google Ads:
Psychology Today & Directories:
When you add it all up: Most providers spend $3,000–$5,000/month on marketing with zero guaranteed patient flow. You’re paying for clicks, not patients. You’re paying for exposure, not appointments.
Klarity (and similar telehealth platforms) operate on a pay-per-appointment model — similar to Zocdoc’s booking fee, but with pre-qualified patients already matched to your specialty and availability.
The key differences:
The ROI comparison:
Let’s say you see 40 patients/month (a realistic telehealth load for med management):
DIY Approach:
Klarity Approach:
For most providers — especially those starting out or scaling — the guaranteed ROI of paying per appointment beats the gamble of marketing spend with uncertain results.
You control your schedule, you see the patients you want to see, and you’re not stuck managing Google Ads campaigns or waiting 9 months for SEO to maybe kick in.
Licensing:
DEA Registration:
PDMP Compliance:
Standard of Care:
Informed Consent:
Can I prescribe benzodiazepines via telehealth for a new patient I’ve never met in person?
Yes, as of 2026, federal rules allow prescribing Schedule IV controlled substances (benzodiazepines like Xanax, Klonopin, Ativan) to new patients via telehealth without an initial in-person visit. This flexibility runs through December 31, 2026.
Do I need a collaborative agreement to prescribe anxiety meds as a PMHNP?
It depends on your state:
Can I prescribe stimulants for anxiety patients with comorbid ADHD via telehealth?
Yes, Schedule II stimulants can be prescribed via telehealth under current federal rules (through 2026). However, some states restrict NP prescribing of Schedule II — for example, Texas NPs can only prescribe Schedule II in hospital/hospice settings. Psychiatrists have no such restriction.
How does reimbursement for telehealth compare to in-person visits?
For mental health services, Medicare and most private insurers pay the same rate for telehealth as in-person visits thanks to parity laws and extended COVID-era flexibilities. Medicaid varies by state but generally covers telehealth at equal rates for mental health.
What happens to telehealth prescribing after December 2026?
The DEA is developing permanent telemedicine prescribing regulations. These may include requirements like a special telemedicine DEA registration or periodic in-person exams, but the details aren’t final. Providers should stay updated on DEA announcements in late 2026.
Can I practice telehealth psychiatry in multiple states?
Yes, but you need a medical license in each state where your patients are located. The Interstate Medical Licensure Compact (IMLC) makes this easier for physicians by streamlining the application process across 40+ states. NPs should check their state’s licensure compact participation.
Do I need separate malpractice insurance for telehealth?
Most malpractice policies now cover telehealth as standard practice, but verify with your insurer. Some policies require notification if you’re practicing across state lines.
Can I prescribe anxiety medications to patients in states with strict telehealth rules?
Yes, as long as you’re licensed in that state and follow its specific requirements. For example, Texas requires a live audio-visual exam to establish the patient relationship, but doesn’t prohibit anxiety medication prescribing via telehealth. Florida allows Schedule II psychiatric prescribing via telehealth if you’re treating a mental health condition.
If you’re a psychiatrist, you have unrestricted authority to prescribe any anxiety medication via telehealth in all 50 states, provided you’re licensed where the patient is located and you follow standard prescribing protocols (PDMP checks, clinical documentation, informed consent).
If you’re a PMHNP, your authority depends on your state’s scope-of-practice laws — but in about half the country, you can prescribe independently, and even in restricted states, you can prescribe with physician collaboration.
The federal telehealth flexibilities run through December 31, 2026, giving you nearly another year of clear regulatory runway to build or scale a telehealth anxiety practice.
The real question isn’t whether you can prescribe via telehealth — it’s whether you want to spend $4,000–$5,000/month gambling on marketing with uncertain results, or join a platform that delivers pre-qualified patients and handles the infrastructure.
For most providers, especially those starting out or looking to scale efficiently, the economics are clear: paying per appointment beats paying per click every time.
Klarity Health connects psychiatrists and PMHNPs with patients who need anxiety treatment — without the marketing gamble, admin headaches, or upfront costs.
What you get:
Join Klarity’s provider network and start seeing anxiety patients on your terms: [Explore Provider Opportunities →]
The following sources were consulted to ensure accuracy and currency of all regulatory, reimbursement, and clinical information (verified as of February 26, 2026):
U.S. Department of Health & Human Services – ‘HHS & DEA Extend Telemedicine Flexibilities Through 2026’ (January 2, 2026)
https://www.hhs.gov/press-room/dea-telemedicine-extension-2026.html
Florida Statutes §464.012 & §456.47 – Nurse Practice Act & Telehealth Prescribing Rules (2024–2025)
https://www.flsenate.gov/laws/statutes/2024/464.012
https://www.flsenate.gov/laws/statutes/2022/456.47
California Board of Registered Nursing – AB 890 Implementation FAQs (Updated 2024)
https://rn.ca.gov/practice/ab890.shtml
Nurse Practitioner Association of New York (NPNY) – ‘NP Modernization Act Passes’ (April 9, 2022)
https://npny.enpnetwork.com/nurse-practitioner-news/216175-breaking-news-np-modernization-act-passes
NursePractitionerLicense.com – Illinois NP Licensure & Limitations (Updated February 12, 2024)
https://www.nursepractitionerlicense.com/nurse-practitioner-licensing-guides/limitations-of-practice-as-a-nurse-practitioner-in-illinois/
Texas Medical Board – FAQ on NP Prescribing of Schedule II Drugs Under Physician Delegation
https://www.tmb.state.tx.us/274-who-can-prescribe-schedule-ii-drugs-under-physician-delegation
Little Health Law Blog – ‘Texas State Telemedicine Prescribing Rules’ (August 29, 2022)
https://www.littlehealthlawblog.com/texas-state-telemedicine-prescribing-rules/
TheraThink – ‘Insurance Reimbursement Rates for Psychiatrists [2026]’ (2025)
https://therathink.com/insurance-reimbursement-rates-for-psychiatrists/
Healing Psychiatry Florida – ‘Psychiatrist Shortage by State – 2026 Report’ (January 15, 2026)
https://www.healingpsychiatryflorida.com/blogs/psychiatrist-shortage-by-state/
MedX Healthcare – ‘Yes, a Nurse Practitioner Can Prescribe Anxiety Meds: Understanding Prescribing Authority’ (November 9, 2025)
https://medx.it.com/yes-a-nurse-practitioner-can-prescribe-anxiety-meds-understanding-prescribing-authority
Axios – ‘COVID-era telehealth prescribing extended again’ (November 18, 2024)
https://www.axios.com/2024/11/18/covid-telehealth-prescribing-extended-adderall
Zivian Health – ‘NP-Physician Collaboration Regulations: 2026 Roadmap’ (February 16, 2026)
https://zivianhealth.com/blog/np-physician-collaboration-regulations-your-compliance-roadmap/
American Medical Association (AMA) – ‘National Advocacy Update: New rules issued for telemedicine prescribing’ (January 24, 2025)
https://www.ama-assn.org/health-care-advocacy/advocacy-update/jan-24-2025-national-advocacy-update
Kiplinger – ‘Medicare Telehealth Expanded in 2025’ (2025)
https://www.kiplinger.com/retirement/medicare/medicare-telehealth-expanded-in-2025
Center for Connected Health Policy (CCHP) – Texas State Telehealth Laws & Policies (Accessed 2026)
https://www.cchpca.org/texas/
All sources were verified for accuracy and currency as of February 26, 2026. Regulatory information reflects the most recent federal and state laws, with pending changes noted where applicable.
Find the right provider for your needs — select your state to find expert care near you.